Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Boehringer Ingelheim Vetmedica Gmbh patents


Recent patent applications related to Boehringer Ingelheim Vetmedica Gmbh. Boehringer Ingelheim Vetmedica Gmbh is listed as an Agent/Assignee. Note: Boehringer Ingelheim Vetmedica Gmbh may have other listings under different names/spellings. We're not affiliated with Boehringer Ingelheim Vetmedica Gmbh, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Boehringer Ingelheim Vetmedica Gmbh-related inventors


Vaccine against porcine parvovirus

The present invention relates to a porcine parvovirus (ppv) viral protein 2 (vp2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said ppv viral protein 2 (vp2). ... Boehringer Ingelheim Vetmedica Gmbh

Immunogenic composition comprising mycoplasma antigens

The present invention relates to an immunogenic composition comprising: a) one or more antigen of m. Hyorhinis and one or more antigens of m. ... Boehringer Ingelheim Vetmedica Gmbh

Cartridge and analysis system for testing a sample

A cartridge, an analysis system, a method and a computer program product for testing a sample, such as, environmental, food or biological sample, wherein the cartridge has two memory means that are different and/or can be read out by different methods and which correspond to the cartridge or to the batch thereof.. . ... Boehringer Ingelheim Vetmedica Gmbh

Method system for testing a sample

An analysis system and a method for testing a biological sample are proposed, wherein certain pieces of at least two different pieces of control information are selected and/or used to carry out the test using a cartridge and/or certain pieces of at least two different pieces of evaluation information are selected and/or used to evaluate the measurement results determined by the test.. . ... Boehringer Ingelheim Vetmedica Gmbh

Analysis system for testing a sample

An analysis system and a method for testing a biological sample is proposed, wherein an operating instrument is provided which preferably can be separated from an analysis device with respect to a data connection and/or wirelessly connected to the analysis device.. . ... Boehringer Ingelheim Vetmedica Gmbh

Analysis system and method for testing a sample

An analysis system and a method for testing a biological sample wherein a plurality of assays selected from at least two assays from a group consisting of a protein assay for detecting a target protein, a nucleic-acid assay for detecting a target nucleic-acid sequence and/or an aptamer assay for detecting another target analyte, the testing is carried out sequentially in a common sensor array by means of a sensor apparatus.. . ... Boehringer Ingelheim Vetmedica Gmbh

Method and analysis system for testing a sample

A method and an analysis system for testing a biological sample, nucleic-acid products being hybridized to capture molecules of a sensor apparatus at different temperatures.. . ... Boehringer Ingelheim Vetmedica Gmbh

Method for controlling an analysis device and analysis system

An analysis system and a method for testing a biological sample is proposed, wherein, before the start of the test, the amount of energy remaining in an energy storage means of the analysis device is compared with an energy requirement for the test, and the test is only started if the amount of energy meets the energy requirement, and/or a temperature-control apparatus designed for temperature-controlling the cartridge is controlled depending on an interior space temperature of the analysis device.. . ... Boehringer Ingelheim Vetmedica Gmbh

Method and analysis system for testing a sample

An analysis system and a method for testing, in particular, a biological sample, the sample and/or analytes of the sample being temperature-controlled in advance or denatured immediately before the test, and/or being heated, the heat being transferred through a chip of a sensor apparatus.. . ... Boehringer Ingelheim Vetmedica Gmbh

Analysis device and method for testing a sample

An analysis device and method for testing a biological sample by means of a receivable cartridge are proposed, the analysis device comprising at least one actuator for actuating a valve of the cartridge. The actuator comprises a pneumatically loaded membrane and an actuation element that is coupled to said membrane, the return movement into an unactuated position being performed preferably as a result of restoring forces of the membrane.. ... Boehringer Ingelheim Vetmedica Gmbh

Cartridge, analysis system and method for testing a sample

A cartridge, an analysis system and a method for analysing an in particular biological sample is proposed, wherein a first group having one or more valves and a second group having one or more valves can be or are actuated from different sides of the cartridge.. . ... Boehringer Ingelheim Vetmedica Gmbh

Analysis device and method for testing a sample

An analysis device and a method for testing a biological sample are proposed, a cartridge being received in the analysis device and valves of the cartridge being opened automatically.. . ... Boehringer Ingelheim Vetmedica Gmbh

Analysis system for testing a sample

An analysis system for testing a biological sample wherein a sensor cover can be or is pneumatically lowered onto a sensor apparatus in order to detect an analyte of the sample.. . ... Boehringer Ingelheim Vetmedica Gmbh

Cartridge for testing a sample

A cartridge for testing a biological sample. The cartridge has a closure element that is fastened to the cartridge in a form-fit or interlocking manner and is a multi-component injection molded closure part having an integrated seal so as to be able to fluidically close a receiving cavity having an integrated vent. ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099276

Analysis system and method for testing a sample

A method for testing a biological sample wherein the sample is divided into a plurality of sample portions, is fed to a sensor arrangement in a first conveying direction and is carried away in a second conveying direction which is opposite to the first conveying direction, and/or a sensor cover is lowered onto a sensor apparatus multiple times. Furthermore, a cartridge for testing a biological sample wherein different fluidic circuits can be formed by actuating valves in the cartridge, and the sample or another fluid can be conveyed in the fluidic circuits by means of a pump apparatus.. ... Boehringer Ingelheim Vetmedica Gmbh

03/22/18 / #20180080047

Promoters

The present invention relates to the field of (vector) vaccines, and especially to novel promoter sequences, expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.. ... Boehringer Ingelheim Vetmedica Gmbh

03/22/18 / #20180080045

Canine adenovirus vectors

The present invention relates to the field of cadv vector vaccines, and especially to promoters suitable to express target antigens from such vector vaccines. Disclosed and claimed are recombinant canine adenoviruses, methods of making them, uses for them (including in immunological, immunogenic, vaccine or therapeutic compositions, or, as a vector for cloning, replicating or expressing dna and methods of using the compositions and vector), expression products from them, and uses for the expression products. ... Boehringer Ingelheim Vetmedica Gmbh

03/22/18 / #20180080044

New swine influenza vaccine

The present invention relates to equine herpes virus (ehv) vectors comprising at least one exogenous antigen encoding sequence relating to a pathogen infecting food producing animals, wherein said exogenous antigen encoding sequence is inserted into an insertion site, preferably orf70, and said exogenous antigen encoding sequence is operably linked to a promoter sequence, preferably the promoter sequence comprising 4pgg600 (seq id no:1) or 4pmcp600 (seq id no:2) or the complementary nucleotide sequences thereof or a functional fragment or a functional derivative thereof or the complementary nucleotide sequences thereof. Furthermore, the present invention relates to methods for immunizing a food producing animal comprising administering to such food producing animal an immunogenic composition comprising embodiments of the present invention. ... Boehringer Ingelheim Vetmedica Gmbh

03/22/18 / #20180080043

Ehv insertion site orf70

The present invention relates to the field of (vector) vaccines, and especially to the novel ehv insertion site orf70. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. ... Boehringer Ingelheim Vetmedica Gmbh

02/08/18 / #20180036316

Treatment of epileptic disorders in feline animals

A method for treatment and/or prevention of one or more epileptic disorders in a feline animal, preferably a cat, includes administration of 1-(4-chlorophenyl)-4-(4-morpholinyl)-2.5-dihydro-1h-imidazol-2-one or a physiologically acceptable salt thereof to the feline animal.. . ... Boehringer Ingelheim Vetmedica Gmbh

12/28/17 / #20170368274

Container for an inhaler

A container for holding, dispensing and/or storing a preferably liquid medicament preparation is proposed, which comprises an inner space for the medicament preparation and an at least partially multi-layered wall structure defining the inner space, the wall structure comprising a first layer with a first through-opening of less than 40 μm. Alternatively or additionally, the wall structure comprises a second and third layer, a second through-opening being provided in the second layer and the third layer covering or closing off the wall structure.. ... Boehringer Ingelheim Vetmedica Gmbh

12/28/17 / #20170368062

Pharmaceutical composition including pimobendan

A solid formulation includes pimobendan or a pharmaceutically acceptable salt thereof, which is homogenously dispersed with a polyvalent acid and a flavor suitable to animals.. . ... Boehringer Ingelheim Vetmedica Gmbh

12/28/17 / #20170367983

Novel low concentration meloxicam tablets

Described herein is a solid tablet that is directly-compressed of powder, including meloxicam and one or more excipients which are homogenously dispersed within the tablet that can be broken into two, three or four units with each unit containing equal amounts of the active ingredient, meloxicam.. . ... Boehringer Ingelheim Vetmedica Gmbh

12/21/17 / #20170360921

Vaccine against infectious bronchitis virus

Embodiments of the present invention relate to an infectious bronchitis virus (ibv) and an immunogenic composition comprising an ibv, respectively, wherein the orf 3a and/or the orf 3b and/or the orf 5a and/or the orf 5b is inactivated. Furthermore, aspects of the present invention relate to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. ... Boehringer Ingelheim Vetmedica Gmbh

12/07/17 / #the present invention is based on the surprising finding that h5 protein of clade 1 h5n1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with h5n1 ha.

Boehringer Ingelheim Vetmedica S.a. De C.v.

. . ... Boehringer Ingelheim Vetmedica Gmbh

10/12/17 / #20170290829

Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

The invention relates to pimobendan for use in a method of reducing the heart size and/or delaying the onset of clinical symptoms in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (mvd), and/or delaying the onset of heart failure, preferably congestive heart failure, in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (mvd), wherein the patient is preferably a mammal, more preferably a human, a dog, a cat or a horse, and most preferably a dog.. . ... Boehringer Ingelheim Vetmedica Gmbh

10/05/17 / #20170281886

Inhaler

An inhaler, preferably for insertion into a nostril, in particular a horse's nostril, with an inhalation valve, which has a movable valve element, whereby the valve element is designed in an annular manner and has an outer edge and an inner edge, whereby the valve element is fastened at the outer edge, the inner edge forms the boundary of an indentation of the valve element, and the inhalation valve has a valve body seat that corresponds to the inner edge.. . ... Boehringer Ingelheim Vetmedica Gmbh

09/07/17 / #20170253908

Quantification of vaccine compositions

The invention provides methods and mass-labeled peptides for use in said methods for quantifying the presence of a one or more viral proteins in a sample of a preparation containing agents which bind to said viral protein, using mass-spectroscopic analyses of the sample and standards containing known amounts of labeled and unlabeled signature peptides, in particular wherein said viral proteins are antigens in a vaccine for porcine circovirus.. . ... Boehringer Ingelheim Vetmedica Gmbh

08/24/17 / #20170241998

Method for the immobilization of biomolecules

The invention relates to a method for the immobilization of biomolecules containing at least one sulfhydryl group, which method comprises contacting a modified metal surface with the biomolecule irradiating the resulting surface with uv radiation in the presence of a photo-initiator, wherein said metal surface is modified with a cross-linker compound comprising a terminal thiol or dithiol group covalently linked to the metal surface, a spacer group, which at the other terminal end is carrying an isolated double or triple bond.. . ... Boehringer Ingelheim Vetmedica Gmbh

08/24/17 / #20170239281

Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals

The present invention relates to combination of one or more sglt2 inhibitors or pharmaceutically acceptable forms and/or salts thereof and one or more dopamine receptor agonists or pharmaceutically acceptable forms and/or salts thereof, preferably in the treatment and/or prevention of a metabolic disorder of an equine animal, wherein more preferably the metabolic disorder is one or more disorders selected from equine metabolic syndrome (ems), equine pituitary pars intermedia dysfunction (ppid), also known as equine cushing's syndrome, laminitis, vascular dysfunction, hypertension, hepatic lipidosis, hyperadreeocorticism, glucose intolerance, insulin resistance, hyperinsulinaemia, hirsutism, hyperhidrosis. Polyuria, polydipsia, chronic infections, abnormal fat distribution, muscle wasting, abnormal weight loss and/or loss of appetite.. ... Boehringer Ingelheim Vetmedica Gmbh

08/17/17 / #20170232094

Porcine circovirus type 2 (pcv2) subunit vaccine

Vaccination methods to control pcv2 infection with different pcv2 subtypes are disclosed. Specifically, a pcv2 subtype b (pcv2b) orf2 proteins or immunogenic compositions comprising a pcv2b orf2 protein are used in a method for the treatment or prevention of an infection with pcv2 of a different subtype, the reduction, prevention or treatment of clinical signs caused by an infection with pcv2 of a different subtype, or the prevention or treatment of a disease caused by an infection with pcv2 of a different subtype.. ... Boehringer Ingelheim Vetmedica Gmbh

06/15/17 / #20170165260

Liquid preparation comprising pimobendan

A liquid preparation includes an etherified cyclodextrin derivative and a substituted benzimidazol, where the etherified cyclodextrin derivative is one of alpha-, beta, and gamma-cyclodextrin ether.. . ... Boehringer Ingelheim Vetmedica Gmbh

06/08/17 / #20170157641

Method for producing a plurality of measurement regions on a chip, and chip having a plurality of measurement regions

A method for producing a plurality of measurement regions on a chip, and a chip having a plurality of measurement regions which is obtainable by the method.. . ... Boehringer Ingelheim Vetmedica Gmbh

05/11/17 / #20170128423

Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats

A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin ii receptor 1 (at-1) antagonist (sartan).. ... Boehringer Ingelheim Vetmedica Gmbh

05/04/17 / #20170119870

Recombinant classical swine fever virus (csfv) comprising substitution in the tav epitope of the e2 protein

The present invention relates i.a. To a csfv (classical swine fever virus) comprising a substitution of proline to lysine at amino acid position 44 of the e2 protein and a substitution of threonine to aspartic acid at amino acid position 45 of the e2 protein. ... Boehringer Ingelheim Vetmedica Gmbh

03/30/17 / #20170087246

Modular antigen transportation molecules and uses thereof in animals

The present invention relates to (isolated) recombinant proteins, also referred to as improved mat (imat) molecules, comprising at least one translocation module, at least one targeting module and at least one antigen module, wherein at least one cysteine residue is substituted with a different amino acid residue. Such imat molecules are useful specifically as vaccines, e.g. ... Boehringer Ingelheim Vetmedica Gmbh

03/30/17 / #20170087241

Prevention and treatment of sub-clinical pcvd

The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (pcv2) antigen for the prevention and treatment of sub-clinical pcv2 infection in animals, preferably in pigs.. . ... Boehringer Ingelheim Vetmedica Gmbh

03/23/17 / #20170079988

Ciclesonide for the treatment of airway disease in horses

The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative or salt thereof, for the treatment of airway disease in horses, such as pulmonary disease, preferably recurrent airway obstruction (rao), summer pasture associated obstructive pulmonary disease (spaopd), and inflammatory airway disease (iad).. ... Boehringer Ingelheim Vetmedica Gmbh

03/16/17 / #20170072042

Salmonella choleraesuis-salmonella typhimurium vaccines

The present invention relates methods of reducing fecal shedding of animals infected with salmonella by use of a vaccine or immunogenic composition of salmonella choleraesuis-typhimurium.. . ... Boehringer Ingelheim Vetmedica Gmbh

03/16/17 / #20170071969

Treatment of metabolic disorders in equine animals

A sglt2 inhibitor or a pharmaceutically acceptable form thereof is provided for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, a sglt2 inhibitor or a pharmaceutically acceptable form thereof is provided for use in the treatment and/or prevention of insulin resistance, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, dysadipokinemia, subclinical inflammation, systemic inflammation, low grade systemic inflammation, obesity, and/or regional adiposity in an equine animal.. ... Boehringer Ingelheim Vetmedica Gmbh

03/09/17 / #20170065709

Novel european prrsv strain

The present invention is related to improved modified live prrs vaccines containing new prrsv european strains of prrsv and methods of use and manufacture of such vaccines.. . ... Boehringer Ingelheim Vetmedica Gmbh

03/02/17 / #the invention relates to novel liquid pharmaceutical compositions comprising at least one sglt-2 inhibitor and one or more polar organic solvents, wherein the at least one sglt-2 inhibitor comprises 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-d-glucopyranos-1-yl)-benzene according to formula (i):

Boehringer Ingelheim Vetmedica Gmbh

. . ... Boehringer Ingelheim Vetmedica Gmbh

02/23/17 / #20170049878

Treatment of prdc in pigs

The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (pcv2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (prdc) in animals, preferably in pigs.. . ... Boehringer Ingelheim Vetmedica Gmbh

02/23/17 / #20170049877

West nile virus vaccine

The invention provides for immunogenic compositions against west nile virus. The immunogenic compositions, in alternate embodiments, also include other equine pathogens. ... Boehringer Ingelheim Vetmedica Gmbh

02/23/17 / #20170049876

Treatment of pigs with pcv2 antigen

The present invention relates to a method for the treatment or prophylaxis of a pcv2 infection or for reduction of clinical symptoms caused by or associated with a pcv2 infection in animals a) having anti-pcv2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a pcv2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.. ... Boehringer Ingelheim Vetmedica Gmbh

02/23/17 / #20170049875

Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs

The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 2 (pcv2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a pcv2 infection. ... Boehringer Ingelheim Vetmedica Gmbh

02/09/17 / #20170035885

Highly concentrated stable meloxicam solutions

Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/ml. The solution is for treating a mammal suffering from one or more of pain, inflammation, fever, acute mastitis, diarrhea, lameness, locomotor deficiency, or respiratory illness.. ... Boehringer Ingelheim Vetmedica Gmbh

02/02/17 / #20170029471

Pcv2 orf2 protein variant and virus like particles composed thereof

Vaccination methods to control pcv2 infection with different pcv2 subtypes are disclosed. Specifically, a pcv2 subtype b (pcv2b) orf2 proteins or immunogenic compositions comprising a pcv2b orf2 protein are used in a method for the treatment or prevention of an infection with pcv2 of the same pcv2b and/or different subtype; the reduction, prevention or treatment of clinical signs caused by an infection with pcv2 of the same pcv2b or a different subtype; and/or the prevention or treatment of a disease caused by an infection with pcv2 of the same pcv2b and/or a different subtype. ... Boehringer Ingelheim Vetmedica Gmbh

01/26/17 / #20170021116

Inhaler

An inhaler, particularly for a horse, having a reservoir for dispensing a medicament preparation held under excess pressure, with a discharge nozzle for forming an aerosol of the medicament preparation and with a chamber for holding and temporarily storing the aerosol, which is located on the outlet side, a respiratory orifice adapter for a respiratory orifice, particularly a nostril, while according to a first aspect the reservoir is secured in position, at least in the axial direction, according to a second aspect the discharge nozzle has a direction of discharge which is inclined by more than 5° and less than 50° relative to a central axis of the reservoir or a direction of actuation for dispensing the aerosol, and according to a third aspect, the reservoir has a dispensing valve which is arranged at the top in the position of use of the inhaler.. . ... Boehringer Ingelheim Vetmedica Gmbh

01/19/17 / #20170014308

Method for the preparation of a vaccinating agent

A method for preparing a vaccine for immunization against the disease porcine circovirus disease and/or enzootic pneumonia in pigs in which a first container is only partly filled with a first vaccine and a second container is filled with a second vaccine, the second vaccine being transferred into the first container through an adapter device, when a closure device is penetrated for the first and/or only time, and the vaccinating agent is prepared therein, thus making the operation simple, less error-prone and more hygienic, while reducing the materials required.. . ... Boehringer Ingelheim Vetmedica Gmbh

01/19/17 / #20170014215

Inhaler

An insert which can be inserted into an inhaler, particularly for a horse has a reservoir for a medicament preparation held under excess pressure and a valve. The insert also has a nebulizer that is held directly on the reservoir and a discharge nozzle, associated with the nebulizer and fluidically connected to the valve, for forming an aerosol with the medicament preparation.. ... Boehringer Ingelheim Vetmedica Gmbh

01/12/17 / #20170007593

Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (lamas)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (rao), summer pasture associated obstructive pulmonary disease (spaopd), and inflammatory airway disease (iad) in animals, preferably equines such as horses.. ... Boehringer Ingelheim Vetmedica Gmbh








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Boehringer Ingelheim Vetmedica Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Boehringer Ingelheim Vetmedica Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###